Tag: Y-mAbs Therapeutics

Y-mAbs begins roll-out of BLA of naxitamab to FDA for neuroblastoma

pharmanewsdaily- December 2, 2019

US biopharma company Y-mAbs Therapeutics has submitted the first portions of its biologics license application (BLA) for naxitamab to the US Food and Drug Administration ... Read More